281 related articles for article (PubMed ID: 8975111)
1. [Mechanism of action, clinical indication and results of treatment of botulinum toxin].
Lagueny A; Burbaud P
Neurophysiol Clin; 1996; 26(4):216-26. PubMed ID: 8975111
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin in clinical practice.
Hughes AJ
Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin. Development for therapeutic purposes].
Ceballos-Baumann A
Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
[TBL] [Abstract][Full Text] [Related]
5. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
Lew MF
Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
[TBL] [Abstract][Full Text] [Related]
6. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
Kaufman DM
J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
[TBL] [Abstract][Full Text] [Related]
7. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
Dutton JJ
Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
[TBL] [Abstract][Full Text] [Related]
8. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
[TBL] [Abstract][Full Text] [Related]
10. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M
Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684
[TBL] [Abstract][Full Text] [Related]
11. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
Hubble J; Schwab J; Hubert C; Abbott CC
Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
[TBL] [Abstract][Full Text] [Related]
12. [Indications and management of botulinum toxin].
Singer C
Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
[TBL] [Abstract][Full Text] [Related]
13. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
Calne S
Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
[TBL] [Abstract][Full Text] [Related]
14. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
15. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
[TBL] [Abstract][Full Text] [Related]
16. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
[TBL] [Abstract][Full Text] [Related]
17. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
Pullman SL; Greene P; Fahn S; Pedersen SF
Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
[TBL] [Abstract][Full Text] [Related]
18. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin therapy for neurologic disorders.
Tim R; Massey JM
Postgrad Med; 1992 May; 91(6):327-32, 334. PubMed ID: 1579537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
